logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Hong Kong stock market anomaly | Sinopharm Health-B (02617.HK) rose over 10%, intending to repurchase shares up to 100 million yuan

date
29/06/2026
According to the Wise Wealth APP, Uni-Bio Science Group Limited (02617.HK) surged more than 10%, as of the time of writing, it rose by 10.33%, to 10.04 Hong Kong dollars, with a trading volume of 36.7399 million Hong Kong dollars.
Latest
4 m ago
Palladium main futures contracts rose by 4% intraday, now trading at 294.25 yuan.
5 m ago
Director Zhu Hexin met with Jane Fraser, Chairperson and CEO of Citigroup.
5 m ago
On June 26, 2026, Zhu Hexin, Vice Governor of the People's Bank of China and Director of the State Administration of Foreign Exchange, met with Jane Fraser, Chairman and CEO of Citigroup, who was visiting. They exchanged views on international economic and financial situations, opportunities for China's economic development, and deepening communication and cooperation. Li Hongyan, Deputy Director of the State Administration of Foreign Exchange, accompanied the meeting.
8 m ago
Hong Kong Stock Market | Fosun Pharma (02696.HK) surged more than 13% in early trading, H medicine received new indications in the European Union, achieving full coverage of first-line treatment for core subtypes of lung cancer.
9 m ago
"BYD registers the trademark 'Didi Shrimp'"
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.